Clinical trial
Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma
NCT03395379 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma
- Lead sponsor
- Centre Hospitalier Universitaire de Nice
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 11, 2012
- Completion date
- May 15, 2016
- Enrollment
- 90 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
unrecognized condition